MARKET

ABSI

ABSI

Absci Corp
NASDAQ
4.530
-0.180
-3.82%
After Hours: 4.550 +0.02 +0.44% 19:09 04/24 EDT
OPEN
4.710
PREV CLOSE
4.710
HIGH
4.890
LOW
4.480
VOLUME
854.64K
TURNOVER
0
52 WEEK HIGH
6.72
52 WEEK LOW
1.111
MARKET CAP
510.91M
P/E (TTM)
-3.7706
1D
5D
1M
3M
1Y
5Y
Moderna and OpenAI in pact to fast-track drug development
Healthcare Tech Moderna and OpenAI in pact to fast-track drug development. About 3,000 employees at Massachusetts-based biotech Moderna will have access to AI firm's ChatGPT Enterprise. Moderna has partnered with AI firm OpenAI to deploy the technology across its business.
Seeking Alpha · 1d ago
Tuesday's ETF Movers: ARKG, PICK
NASDAQ · 1d ago
Tuesday Sector Leaders: Diagnostics, Biotechnology Stocks
NASDAQ · 1d ago
Both retail investors who control a good portion of Absci Corporation (NASDAQ:ABSI) along with institutions must be dismayed after last week's 16% decrease
Absci Corporation's (NASDAQ:ABSI) top 14 shareholders own 50% of the company. Institutions own 27% of Absci. Retail investors own the maximum number of shares in Absci with a 44% stake. The company is owned by a number of different types of shareholders. Absci has a high level of insider ownership, but the company could be vulnerable to insider selling. It's worth looking at Absci's earnings history to see if any insiders are buying the stock.
Simply Wall St · 2d ago
Weekly Report: what happened at ABSI last week (0415-0419)?
Weekly Report · 3d ago
ENPH, OCUL and ITCI are among after hour movers
Seeking Alpha · 04/16 21:02
Weekly Report: what happened at ABSI last week (0408-0412)?
Weekly Report · 04/15 09:13
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
NASDAQ · 04/10 15:07
More
About ABSI
Absci Corporation is a generative artificial intelligence (AI) drug creation company. The Company combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. The Company uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. The Company supports its generative AI designs with its wet lab's high-throughput functional validation capabilities. It reconstructs prevalent immune-response molecules, such as antibodies from disease tissue and identify their corresponding antigens, offering new therapeutic targets.

Webull offers Absci Corp stock information, including NASDAQ: ABSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABSI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABSI stock methods without spending real money on the virtual paper trading platform.